Ito Toshiro, Yamada Akira, Batal Ibrahim, Yeung Melissa Y, McGrath Martina M, Sayegh Mohamed H, Chandraker Anil, Ueno Takuya
Transplantation Unit, Surgical Services, Massachusetts General Hospital, Harvard Medical School , Boston, MA , USA.
Transplantation Research Center, Brigham and Women's Hospital and Children's Hospital, Harvard Medical School , Boston, MA , USA.
Front Immunol. 2016 Mar 9;7:82. doi: 10.3389/fimmu.2016.00082. eCollection 2016.
We have previously found that CD4(+)CD25(+) regulatory T cells (Tregs) can adoptively transfer tolerance after its induction with costimulatory blockade in a mouse model of murine cardiac allograft transplantation. In these experiments, we tested an hypothesis with three components: (1) the Tregs that transfer tolerance have the capacity for linked suppression, (2) the determinants that stimulate the Tregs are expressed by the indirect pathway, and (3) the donor peptides contributing to these indirect determinants are derived from donor major histocompatibility complex (MHC) antigens (Ags).
First heart transplants were performed from the indicated donor strain to B10.D2 recipients along with costimulatory blockade treatment (250 μg i.p. injection of MR1 on day 0 and 250 μg i.p. injection of CTLA-4 Ig on day 2). At least 8 weeks later, a second heart transplant was performed to a new B10.D2 recipient who had been irradiated with 450 cGy. This recipient was given 40 × 106 naive B10.D2 spleen cells + 40 × 106 B10.D2 spleen cells from the first (tolerant) recipient. We performed three different types of heart transplants using various donors.
(1) Tregs suppress the graft rejection in an Ag-specific manner. (2) Tregs generated in the face of MHC disparities suppress the rejection of grafts expressing third party MHC along with tolerant MHC.
The limits of linkage appear to be quantitative and not universally determined by either the indirect pathway or by peptides of donor MHC Ags.
我们之前发现,在小鼠心脏同种异体移植模型中,共刺激阻断诱导产生的CD4(+)CD25(+)调节性T细胞(Tregs)能够过继转移免疫耐受。在这些实验中,我们用三个部分验证了一个假说:(1)转移免疫耐受的Tregs具有连锁抑制能力;(2)刺激Tregs的决定簇通过间接途径表达;(3)促成这些间接决定簇的供体肽源自供体主要组织相容性复合体(MHC)抗原(Ags)。
将指定供体品系的心脏首次移植到B10.D2受体,并进行共刺激阻断治疗(第0天腹腔注射250μg MR1,第2天腹腔注射250μg CTLA-4 Ig)。至少8周后,将心脏再次移植到接受过450cGy照射的新B10.D2受体。该受体接受40×10⁶个未经致敏的B10.D2脾细胞 + 40×10⁶个来自第一个(耐受)受体的B10.D2脾细胞。我们使用不同供体进行了三种不同类型的心脏移植。
(1)Tregs以抗原特异性方式抑制移植物排斥反应。(2)面对MHC差异产生的Tregs抑制表达第三方MHC以及耐受MHC的移植物的排斥反应。
连锁的限度似乎是定量的,并非普遍由间接途径或供体MHC Ags的肽所决定。